Memorial Sloan Kettering Cancer Center Neurology is a clinical research site located in New York, New York, United States 90033.
Crixeo Health Trust Score: 41/100 (POOR). This profile has not yet been claimed by the site owner.
Memorial Sloan Kettering Cancer Center Neurology has participated in 1 clinical trials.
Therapeutic areas: c-MET Inhibitor; PI3K Inhibitor, PTEN Mutations, Homozygous Del. of PTEN or PTEN Neg. by IHC, c-Met Ampli. by FISH, INC280, BKM120, Buparlisib; Recurrent GBM.
Sponsors: Novartis Pharmaceuticals.
Trust Score: 41/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.
Memorial Sloan Kettering Cancer Center Neurology has a Crixeo Trust Score of 41/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.
Memorial Sloan Kettering Cancer Center Neurology has 1 clinical trials on record. Their work covers c-MET Inhibitor; PI3K Inhibitor, PTEN Mutations, Homozygous Del. of PTEN or PTEN Neg. by IHC, c-Met Ampli. by FISH, INC280, BKM120, Buparlisib; Recurrent GBM.
Memorial Sloan Kettering Cancer Center Neurology has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.
Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.